Apitoxin Versus Soft Laser for Management of Aphthous Ulceration. (NCT07135609) | Clinical Trial Compass
CompletedNot Applicable
Apitoxin Versus Soft Laser for Management of Aphthous Ulceration.
Egypt60 participantsStarted 2024-04-30
Plain-language summary
The current study evaluated the clinical effect and outcome of locally applied bee venom versus low-level laser therapy (LLLT) for the treatment of recurrent aphthous ulceration.
Who can participate
Age range15 Years ā 40 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age from 15 to 40 years old.
* Both sexes.
* No current or history of systemic medical problem.
* Non-smoker.
* Suffering from pain due to recurrent aphthous stomatitis (RAS) ulceration on the oral mucosa with the following characteristics:
* Duration of 2 days or less.
* The diameter ā„ 4mm
* Not been subjected to any treatment modalities for at least four weeks before the beginning of the study.
Exclusion Criteria:
* Presence of other oral mucosal ulcers other than RAS.
* Systemic disease that predisposed them to RAS (e.g., BehƧet disease).
* Systemic medical problems.
* Pregnant, lactating, and postmenopausal patients.
* Smoker patients.
* Systemic or topical treatment for RAS less than four weeks before starting the study.
* Any earlier experiences of laser therapy.